Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
clinicaltrialsarena
16h
Johnson & Johnson’s CARVYKTI improves survival in multiple myeloma trial
Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.
clinicaltrialsarena
13h
mRNA Covid-19 vaccines may boost cancer immunotherapy effectiveness
The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Dockworkers launch strike
Pete Rose dies at 83
Helene wreaks havoc
NBA Hall of Famer dies
Illegal cloning sentencing
NYC tunnel shutdown
Lose 'superhero' trademark
Mich. nuclear plant to restart
Three PFLP leaders killed
Settlement checks delayed
To sue Google, Samsung
SpaceX Falcon 9 grounded
Sells stake in DirecTV
Israel announces operation
Signals more rate cuts
194K Jeep SUVs recalled
Nepal floods: Death toll rises
Sues US Senate committee
Comer subpoenas Mayorkas
$567M Taiwan defense aid
Ozzie Virgil Sr. dies at 92
Settles data breach cases
To lay off 2,900 employees
Seeks bribery dismissal
Asylum restrictions extended
'Sing Sing' actor exonerated
Red Sox honor radio voice
Feedback